Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Doc Ophthalmol. 2010 Nov 3;122(1):19–27. doi: 10.1007/s10633-010-9251-0

Long Term Effects of Retinopathy of Prematurity (ROP) on Rod and Rod-Driven Function

Maureen E Harris 1, Anne Moskowitz 1, Anne B Fulton 1, Ronald M Hansen 1
PMCID: PMC3041841  NIHMSID: NIHMS250307  PMID: 21046193

Abstract

Purpose

To determine whether recovery of scotopic sensitivity occurs in human ROP, as it does in rat models of ROP.

Methods

Following a cross-sectional design, scotopic electroretinographic (ERG) responses to full-field stimuli were recorded from 85 subjects with a history of preterm birth. In 39 of these subjects, dark adapted visual threshold was also measured. Subjects were tested post term as infants (median age 2.5 months) or at older ages (median age 10.5 years) and stratified by severity of ROP: severe, mild, or none. Rod photoreceptor sensitivity, SROD, was derived from the a-wave and post-receptor sensitivity, log σ, was calculated from the b-wave stimulus-response function. Dark adapted visual threshold was measured using a forced-choice preferential procedure.

Results

For SROD, the deficit from normal for age varied significantly with ROP severity but not with age group. For log σ, in mild ROP, the deficit was smaller in older subjects than in infants, while in severe ROP, the deficit was quite large in both age groups. In subjects who never had ROP, SROD and log σ in both age groups were similar to those in term born controls. Deficits in dark adapted threshold and log σ were correlated in mild but not in severe ROP.

Conclusions

The data are evidence that sensitivity of the post-receptor retina improves in those with a history of mild ROP. We speculate that beneficial reorganization of the post-receptor neural circuitry occurs in mild but not in severe ROP.

Keywords: retinopathy of prematurity, neural retina, electroretinogram, rod photoreceptor, dark adapted visual threshold


Retinopathy of prematurity (ROP), even if mild, causes long term deficits in rod and rod-driven post-receptor retinal function that persist long after acute phase ROP has resolved. Compared to term born controls, in the majority of ROP subjects, both rod photoreceptor and post-receptor response parameters are below average from early infancy into adulthood; former preterms who never had ROP do not differ from age-similar controls [1]. Rod and post-receptor retinal dysfunction are also noted in rat models of ROP [29]. In rats followed longitudinally, postreceptor sensitivity recovers whereas photoreceptor sensitivity remains abnormal [2].

To determine if there is evidence of recovery of sensitivity in human ROP, we reviewed rod photoreceptor and post-receptor ERG parameters in infants and older subjects with a history of preterm birth. Dark adapted visual thresholds were also evaluated for significant relationship to ERG indices of sensitivity. The effects of age and ROP severity on these cross-sectional ERG and threshold data from infant and older subjects were analyzed.

METHODS

Subjects

Rod and rod-driven ERG parameters from 85 subjects with a history of preterm birth were analyzed (Table 1A). Peripheral dark adapted visual thresholds obtained from 39 of these subjects were also analyzed (Table 1B). ERG parameters from 68 of the subjects [1] and threshold data from 11 [10] have been reported previously.

Table 1.

Former preterm subjects [median (range)]

A. ERG subjects

Category n Gestational Age
(weeks)
Birth Weight
(g)
Age at Test
(post-term)
Infants (n = 35)
   Severe ROP 5 27.0 (25 to 28) 950 (499 to 1040) 11.6 (9.0 to 31.3) weeks
   Mild ROP 21 27.0 (24 to 31) 890 (610 to 1332) 10.3 (7.4 to 36.3) weeks
   No ROP 9 29.0 (25 to 32) 1270 (740 to 2275) 10.3 (9.1 to 33.8) weeks

Older (n = 50)
   Severe ROP 9 26.0 (24 to 30) 634 (490 to 1750) 10.0 (5.9 to 18.5) years
   Mild ROP 29 25.0 (23 to 32) 760 (500 to 1588) 11.1 (3.1 to 23.0) years
   No ROP 12 30.5 (26 to 32) 1424 (820 to 2268) 9.8 (3.1 to 18.1) years
B. Subset of ERG subjects with dark adapted visual thresholds

Category n Gestational Age
(weeks)
Birth Weight
(g)
Age at Test
(post-term)
Infants (n = 20)
   Severe ROP 5 27.0 (25 to 28) 950 (499 to 1040) 11.7 (9.4 to 32.9) weeks
   Mild ROP 11 28.0 (24 to 30) 940 (610 to 1230) 10.7 (7.6 to 18.9) weeks
   No ROP 4 28.0 (27 to 30) 1250 (1195 to 1270) 10.5 (9.9 to 11.3) weeks

Older (n = 19)
   Severe ROP 4 25.5 (24 to 28) 634 (490 to 1100) 10.4 (6.7 to 14.5) years
   Mild ROP 12 25.5 (24 to 32) 785 (595 to 1588) 11.6 (3.1 to 14.9) years
   No ROP 3 26.0 (26 to 30) 930 (820 to 1400) 7.7 (3.0 to 13.9) years

All subjects had serial fundus examinations in the newborn intensive care nursery similar to those used in the multi-center ROP treatment trials [11, 12]. Based on these examinations, the subjects were categorized according to maximum acute phase ROP as severe, treated ROP (n = 14), mild, untreated ROP (n = 50), or no ROP (n = 21) [13, 14]. Those in the severe category were treated by ablation of avascular peripheral retina. Those in the mild category did not require treatment; by clinical criteria, their ROP resolved completely. Those in the no ROP category had serial examinations and ROP was never detected. No subject had active ROP at the time of the ERG test and none had a history of retinal detachment or surgery other than laser or cryotherapy.

Gestational age at birth ranged from 23 to 32 (median 27) weeks and birth weight from 490 to 2,275 (median 845) grams (Table 1A). Although, on average, those with severe ROP were born earlier and had lower birth weights, there was considerable overlap in gestational age at birth and birth weight among the three groups.

The 85 subjects were stratified into two age groups: infant and older (Table 1A). Infants (n = 35) were tested at median age 10.3 (range 7.4 to 36.3) weeks post-term. Older subjects (n = 50) were tested at median age 10.5 (range 3.1 to 23.0) years post-term. The demographics of the subset with dark adapted visual thresholds are summarized in Table 1B. Throughout this paper, we report age of former preterm subjects as post-term age. Post-term age is calculated by subtracting the difference between the gestational age at birth and full term (40 weeks) from the subject’s postnatal age: Post-term age = Postnatal age – (Term – Gestational Age). For example, the post-term age of an infant born at 26 weeks gestation and tested at postnatal age 24 weeks is 10 weeks [24 – (40 – 26) = 10].

This study conformed to the tenets of the Declaration of Helsinki and was approved by the Children’s Hospital Committee on Clinical Investigation. Informed consent was obtained from the parents of the infants and children, assent from the older children, and consent from those 18 years and older.

ERG procedure

The majority of preterm subjects (70/85; 82%) were tested with Burian-Allen corneal contact electrodes. Skin electrodes were used in 15 of the 50 older preterm subjects who were judged unlikely to tolerate the Burian-Allen electrode. The skin electrode subjects were median age 6.9 (range 3.0 to 11.9) years and were distributed across ROP strata (severe: n = 3, mild: n = 9, no ROP: n = 3). ERGs from preterms were compared to those from term born 10 week old infants (n = 38) and mature (n = 60) subjects [1]. All controls were tested with Burian-Allen electrodes; 18 of the mature controls were also tested using skin electrodes.

Parents stayed with infants and children throughout the procedure. One pupil was dilated with cyclopentolate 1% and the subject was dark adapted for 30 minutes. Then, under dim red light, proparacaine 0.5% was instilled and a bipolar Burian-Allen electrode was placed on the cornea. For skin electrode testing, the active electrode was placed near the outer canthus and the indifferent electrode below the lower lid [15]. For both electrode types, a ground electrode was placed on the skin over the ipsilateral mastoid.

A Compact 4 system (Nicolet, Madison, WI) was used to test 55 and an Espion system (Diagnosys, Lowell, MA) was used to test 30 of the former preterm subjects. Rod responses were recorded using a Wratten 47B filter (λ < 510 nm) in the Nicolet system and a 470 nm LED (half bandwidth 30 nm) in the Espion system. In both systems, the gain was 1000 and the bandpass was 0.5 to 1000 Hz. The digitization rate was 2,564 Hz for the Nicolet and 2,000 Hz for the Espion. In the adult control subjects (Nicolet: n = 28; Espion: n = 32), rod photoreceptor and post-receptor parameters did not differ between the two recording systems. Therefore, data obtained using the two systems have been combined in all analyses.

Rod photoreceptor

The activation of phototransduction was studied in all subjects. Responses to full-field, brief (< 3 ms), blue stimuli ranging from +2.1 to +3.6 log scot td s were recorded. The rod photoresponse parameters (SROD and RROD) were calculated by fit of the Hood and Birch [16] formulation of the Lamb and Pugh model [17, 18] to the a-waves. The equation is

R(i,t)=[1exp{0.5 I SROD(ttd)2}]  RROD (1)

where I is the flash (scot td s), SROD a parameter [(scot td)−1 s−3] that depends on the time constants of the steps in activation of phototransduction [18], RROD, the saturated response amplitude (μV), and td, a brief delay (ms). All three parameters (SROD, RROD, and td) were free to vary.

Post-receptor rod-driven b-wave

The stimulus/response function

V(I)=[I/(I+σ)]VMAX (2)

was fit to the b-wave amplitudes of each subject. In this equation, V is the b-wave amplitude (μV) produced by flash intensity I, VMAX the saturated amplitude (μV), I the stimulus in scot td s, and σ the stimulus that evokes a half-maximum b-wave amplitude. Thus, 1/σ is a measure of sensitivity.

The function was fit only up to those higher intensities at which substantial a-wave intrusion occurred (~ +1.0 log scot td s) [19]. Under these rod-mediated conditions, the b-wave represents the activity of ON bipolar and other second and third order neurons [20, 21].

Validation of parameters obtained using skin electrodes

In a preliminary analysis, we tested adult, term born control subjects (n = 18) with both the Burian-Allen electrode and skin electrodes (Table 2). There was no significant difference (repeated measures t-test) in estimates of SROD or log σ, but skin electrode amplitudes (RROD and VMAX) were significantly smaller than Burian-Allen amplitudes. In an individual, the difference between Burian-Allen and skin electrode estimates of both SROD and log σ was small. Specifically, the median difference in log SROD was +0.04 (range −0.24 to +0.17 log unit) and the median difference in log σ was +0.02 (range −0.19 to +0.40 log unit). Thus, SROD and log σ parameters obtained with skin and Burian-Allen electrodes were combined. For every individual, saturated amplitudes (RROD and VMAX) obtained with skin electrodes were considerably smaller than those obtained with the Burian-Allen electrode [RROD: median 16% (range 6% to 31%); VMAX: median 16% (range 11% to 34%)].

Table 2.

Comparison of Burian-Allen and skin electrode results in mature, term born controls [median (range)]

Rod Photoreceptor Post-receptor
SROD
(scot td s)
RROD
(μV)
Log σ
(scot td s)
VMAX
(μV)
Burian-Allen 84.9 (53.6 to 110.5) 395 (137 to 541) −0.8 (−1.1 to −0.2) 431 (305 to 566)
Skin 73.0 (12.8 to 123.8) 58 (17 to 97) −0.8 (−1.2 to −0.1) 72 (42 to 115)

Psychophysical thresholds

Peripheral visual thresholds were estimated using a two-alternative, forced-choice method, as previously described [22]. After dark adapting for 30 minutes, the subject was positioned in front of a rear projection screen. A 30 minarc diameter, flickering, red light attracted the subject's gaze to the center of the screen. When an adult observer reported that the subject was looking at the center, the fixation target was extinguished and a peripheral test stimulus presented. Stimuli were 50 ms duration, blue (Wratten 47B, λ < 510 nm), 2° diameter spots presented 30° to the right or left of the fixation target. Stimulus intensity was controlled using calibrated neutral density filters. The observer, unaware of the right-left position of the test stimulus, reported stimulus location, right or left, based on the subject’s head and eye movements. Older subjects pointed to the stimulus or reported its location verbally. Thresholds were determined using a transformed up-down staircase that estimated the 70.7% correct point of the psychometric function [23].

Calibrations

Stimuli were measured with a detector and appropriate scotopic filter (IL 1700, International Light, Newburyport, MA) placed at the position of the subject’s cornea. The maximum intensity stimulus was 79.2 scotopic cd/m2 in the ERG system and 5.0 scotopic cd/m2 in the psychophysical apparatus. In adults, assuming a pupil diameter of 8 mm, the ERG stimulus produced approximately +3.6 log scot td s and the psychophysical stimulus approximately +2.4 log scot td s. In our analysis of rod photoreceptor and post-receptor function, we used the same troland values for both infant and older subjects.

Retinal illuminance varies directly with area of the pupil and transmissivity of the ocular media and inversely with the square of the posterior nodal distance [24, 25]. The infants’ median pupil diameter was 5.0 mm. We used the area of each infants’ dilated pupil and published estimates of the ocular media density [26] and axial length of the eye [27] to estimate the retinal illuminance. In summary, equal intensity stimuli produce retinal illuminance in 10 week old infants that differs from that in older subjects by less than 0.1 log unit [1, 2830]. For the ERG system, the maximum stimulus was 6.13 lm/m2; for the psychophysical apparatus, it was 0.44 lm/m2.

Statistical analyses

For each subject, ERG parameters (SROD, log σ, RROD and VMAX) were expressed as the log of the difference from the calculated normal value for age [31]. In normal development, these parameters do not change significantly after infancy [31].

Analysis of variance (ANOVA) was used to evaluate the effect of ROP severity (severe, mild, no ROP) and age (infant, older) on each ERG parameter. All ANOVA results are summarized in Table 3.

Table 3.

Results of analyses of variance

Sensitivity (Δ log normal for age)
Photoreceptor (SROD) Post-receptor (log σ)
F df p F df p


Severity 19.31 2, 79 <0.001 8.61 2, 79 <0.01
Age 3.04 1, 79 ns 0.47 1, 79 ns
Age × Severity 0.30 2, 79 ns 5.32 2, 79 <0.01

Saturated Amplitude (Δ log normal for age)
Photoreceptor (RROD) Post-receptor (VMAX)
F df p F df p


Severity 5.09 2, 79 <0.01 7.89 2, 79 <0.01
Age 3.75 1, 79 ns 0.64 1, 79 ns
Age×Severity 0.64 2, 79 ns 0.09 2, 79 ns

For those subjects who had dark adapted visual threshold measured, linear regression was used to compare deficit in threshold for significant relationship to deficit in photoreceptor (SROD) and post-receptor (log σ) sensitivity. Thresholds and ERG parameters were expressed as difference from mean adult control values [31].

The level of significance for all tests was p ≤ 0.01.

RESULTS

Sample ERG records (Fig. 1) from two mild ROP subjects are shown, one recorded using a Burian-Allen electrode, the other recorded with skin electrodes. Model fits to the a-wave and the b-wave stimulus response functions are also shown.

Fig. 1.

Fig. 1

Sample ERG records from mild ROP subjects. a. ERGs recorded using a Burian-Allen contact electrode and model fits to a- and b-waves in a 10 week old infant with a history of mild ROP. Left: Dark adapted ERG responses to a series of flashes. Flash intensity in log scot td s is indicated to the left of the traces. Upper right: The first 40 ms of the response (solid lines) to the five brightest flashes and model fits to the a-wave (Eq. 1, dashed lines). The calculated values of SROD and RROD are indicated. Lower right: b-wave amplitude plotted as a function of stimulus intensity. The smooth curve represents Eq. 2 fit to the points. The calculated values of log σ and VMAX are indicated. b. ERGs recorded using skin electrodes in a 7 year old child with a history of mild ROP. The features are the same as in a.

Mean values of sensitivity parameters SROD and log σ expressed as the log of the difference from normal for age (Δ log normal) are shown for each ROP category and age group in Fig. 2. ANOVA (Table 3) showed that deficits in log SROD (upper panel) varied significantly with ROP severity but not with age. On average, the SROD deficit in the severe category was 0.38 log unit (infant) and 0.32 log unit (older); that is, sensitivity was 42% and 48% of that in the controls. In those with mild ROP, the SROD deficit was smaller: 0.22 log unit (infant) and 0.12 log unit (older); that is, sensitivity was 60% and 76% of that in controls. For those with no ROP, SROD was normal at both ages.

Fig. 2.

Fig. 2

Mean (SEM) sensitivity expressed as the log of the difference from normal for age (Δ log normal). Upper panel: Rod photoreceptor sensitivity, SROD. In both mild and severe ROP, significant deficits in SROD were seen in infants and older subjects. Lower panel: Rod post-receptor sensitivity, log σ. In infants, log σ was low in those with a history of ROP, whether mild or severe. In older subjects, deficits in log σ were smaller in mild than in severe ROP.

Deficits in post-receptor sensitivity are summarized in Fig. 2, lower panel. The deficit in log σ varied significantly with ROP severity but not with age (Table 3). Of note, there was a significant interaction of age and ROP severity. In subjects with a history of mild ROP, the deficit in log σ was significantly smaller in the older group than in the infant group (t = 6.74; df = 79; p < 0.01), while in subjects with a history of severe ROP, large deficits were found in both age groups; the latter deficits were not significantly different.

Deficits in rod photoreceptor and post-receptor saturated amplitude (RROD and VMAX, respectively) are summarized in Fig. 3. The deficits in both log RROD and log VMAX varied significantly with severity but not with age (Table 3). Both amplitude parameters were lowest in severe ROP. There was no significant interaction of age and ROP severity for either amplitude parameter.

Fig. 3.

Fig. 3

Mean (SEM) saturated amplitude expressed as the log of the difference from normal for age (Δ log normal). Upper panel: Rod photoreceptor saturated amplitude, RROD. Lower panel: Post-receptor saturated amplitude, VMAX. The deficit in both amplitude parameters was greatest in severe ROP.

Deficit in peripheral dark adapted visual threshold is plotted as a function of deficit in post-receptor sensitivity in Fig. 4. In the no ROP subjects (upper panel), as in normal development, the deficit in psychophysical threshold was predicted by the deficit in log σ. In mild ROP (center panel), deficits in log σ and peripheral threshold were similar; the points fell near the diagonal line (slope = 1.0) that indicates equal deficits in both. There was a significant relationship between deficit in threshold and deficit in log σ (y = 0.44x – 11; r = 0.46; t = 3.50; p < 0.001). The slope of the regression line did not differ significantly from 1.0. In severe ROP (lower panel), there was no relationship between deficit in threshold and deficit in log σ

Fig. 4.

Fig. 4

Deficit in dark adapted peripheral threshold (Δ log DAT) plotted as a function of deficit in post-receptor sensitivity (Δ log σ) in preterm subjects with a history of no ROP (top), mild ROP (middle), and severe ROP (bottom). The circles represent data from individual preterm subjects (open circles – infants; filled circles – older subjects). The triangles indicate the mean (±SEM) for term born 10-week old infants (open) and adults (filled). The mean normal adult value is at coordinates (0,0). The solid line has a slope of 1.

In normal development, photoreceptor sensitivity (SROD) predicts dark adapted visual threshold elevation [32]. In ROP, whether mild or severe, there was no significant relationship between SROD and threshold (not shown). The relationship in subjects with no ROP was similar to that in normal development.

DISCUSSION

Small but statistically significant deficits in rod photoreceptor sensitivity, SROD, are seen in both infants and older subjects with a history of mild and severe ROP (Fig. 2, upper panel). Photoreceptors appear to be a therapeutic target in ROP. Pharmacological protection of immature photoreceptors benefits the neurovascular outcome in a rat model of ROP [33].

Deficits in post-receptor sensitivity, represented by log σ, are seen in infants with a history of mild and severe ROP. In older subjects, the log deficits are minimal in mild ROP but marked in severe ROP (Fig. 2, lower panel). These cross-sectional ERG data from young infants and older subjects (>3 years) suggest that in mild ROP, post-receptor sensitivity improves after early infancy. In mild ROP, deficits in post-receptor sensitivity and deficits in threshold are correlated (Fig. 4, middle panel). Our previous longitudinal psychophysical measures of dark adapted visual threshold [10] indicated that in mild ROP, peripheral retinal sensitivity reached maturity in late infancy (9 to 12 months post term). Therefore, we predict that post-receptor sensitivity (log σ) also matures in late infancy. In term born controls, peripheral sensitivity is mature by age 6 months [22].

We hypothesize that in mild ROP patients, beneficial reorganization (“rewiring”) of post-receptor retinal circuitry leads not only to improved ERG sensitivity but to normal visual thresholds [10]. We have previously observed beneficial reorganization in a patient with desferoxamine toxicity [34] whom we have now followed for more than a decade. Pharmacological exposure caused photoreceptor, post-receptor, and visual dysfunction. Mild rod dysfunction (SROD) was irreversible but post-receptor function (log σ) and visual threshold recovered [34]. In animals, more severe injury to the photoreceptors, due to light damage or heritable degeneration, causes marked, detrimental remodeling of the post-receptor retina [3537]. We suspect that in mild human ROP, step-wise, beneficial remodeling of neural and vascular elements occurs. Growth factors mediate neural-vascular cross talk during the evolution and resolution of ROP in a rat model [38]. Analogous processes may be operative in human ROP.

The apparent lack of post-receptor recovery in severe ROP could be consequent to the intimate relationship of the post-receptor neural retina and its vascular supply. By definition, acute vascular abnormalities are more marked in severe than in mild ROP and may be associated with irreparable injury to the post-receptor neural circuitry. We cannot exclude the possibility that in some patients with severe ROP, the post-receptor circuitry recovers by late infancy only to lose function in childhood. We have, however, found no evidence of this in the extant data (Figure 2, lower panel).

Further delineation of the interplay of the post-receptor neural circuitry and the retinal vasculature is essential for understanding of the recovery of function in mild ROP and the apparent lack of recovery in severe ROP. Such understanding may lead to improved clinical outcomes, perhaps by identifying new therapeutic targets. Complementary analyses of vasculature and retinal layer morphology [3941] and of function, assessed using ERG and psychophysical methods, will provide the critical information in infants and children. Interpretation of the retinal processes in human ROP will undoubtedly continue to be informed by the results of investigations in rat models [2, 33, 38, 4245].

Acknowledgments

This work was supported by National Eye Institute Grant R01 EY010597.

REFERENCES

  • 1.Fulton AB, Hansen RM, Moskowitz A, Akula JD. The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res. 2009;28:452–482. doi: 10.1016/j.preteyeres.2009.06.003. Corrigendum 2010;29:94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Akula JD, Hansen RM, Martinez-Perez ME, Fulton AB. Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48:4351–4359. doi: 10.1167/iovs.07-0204. [DOI] [PubMed] [Google Scholar]
  • 3.Akula JD, Mocko JA, Moskowitz A, Hansen RM, Fulton AB. The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48:5788–5797. doi: 10.1167/iovs.07-0881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Liu K, Akula JD, Falk C, Hansen RM, Fulton AB. The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2006;47:2639–2647. doi: 10.1167/iovs.06-0016. [DOI] [PubMed] [Google Scholar]
  • 5.Liu K, Akula JD, Hansen RM, Moskowitz A, Kleinman MS, Fulton AB. Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest Ophthalmol Vis Sci. 2006;47:5447–5452. doi: 10.1167/iovs.06-0702. [DOI] [PubMed] [Google Scholar]
  • 6.Dembinska O, Rojas LM, Chemtob S, Lachapelle P. Evidence for a brief period of enhanced oxygen susceptibility in the rat model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2002;43:2481–2490. [PubMed] [Google Scholar]
  • 7.Dembinska O, Rojas LM, Varma DR, Chemtob S, Lachapelle P. Graded contribution of retinal maturation to the development of oxygen-induced retinopathy in rats. Invest Ophthalmol Vis Sci. 2001;42:1111–1118. [PubMed] [Google Scholar]
  • 8.Dorfman AL, Chemtob S, Lachapelle P. Postnatal hyperoxia and the developing rat retina: beyond the obvious vasculopathy. Doc Ophthalmol. 2010;120:61–66. doi: 10.1007/s10633-009-9208-3. [DOI] [PubMed] [Google Scholar]
  • 9.Fletcher EL, Downie LE, Hatzopoulos K, Vessey KA, Ward MM, Chow CL, Pianta MJ, Vingrys AJ, Kalloniatis M, Wilkinson-Berka JL. The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy. Doc Ophthalmol. 2010;120:67–86. doi: 10.1007/s10633-009-9193-6. [DOI] [PubMed] [Google Scholar]
  • 10.Barnaby AM, Hansen RM, Moskowitz A, Fulton AB. Development of scotopic visual thresholds in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48:4854–4860. doi: 10.1167/iovs.07-0406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results Arch Ophthalmol. 1988;106:471–479. doi: 10.1001/archopht.1988.01060130517027. [DOI] [PubMed] [Google Scholar]
  • 12.Hardy RJ, Good WV, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B. Multicenter trial of early treatment for retinopathy of prematurity: study design. Control Clin Trials. 2004;25:311–315. doi: 10.1016/j.cct.2004.03.003. [DOI] [PubMed] [Google Scholar]
  • 13.International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123:991–999. doi: 10.1001/archopht.123.7.991. [DOI] [PubMed] [Google Scholar]
  • 14.Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–1694. doi: 10.1001/archopht.121.12.1684. [DOI] [PubMed] [Google Scholar]
  • 15.Bradshaw K, Hansen R, Fulton A. Comparison of ERGs recorded with skin and corneal-contact electrodes in normal children and adults. Doc Ophthalmol. 2004;109:43–55. doi: 10.1007/s10633-004-1751-3. [DOI] [PubMed] [Google Scholar]
  • 16.Hood DC, Birch DG. Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci. 1994;35:2948–2961. [PubMed] [Google Scholar]
  • 17.Lamb TD, Pugh EN., Jr A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J Physiol. 1992;449:719–758. doi: 10.1113/jphysiol.1992.sp019111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pugh EN, Jr, Lamb TD. Amplification and kinetics of the activation steps in phototransduction. Biochim Biophys Acta. 1993;1141:111–149. doi: 10.1016/0005-2728(93)90038-h. [DOI] [PubMed] [Google Scholar]
  • 19.Peachey NS, Alexander KR, Derlacki DJ, Fishman GA. Light adaptation and the luminance-response function of the cone electroretinogram. Doc Ophthalmol. 1992;79:363–369. doi: 10.1007/BF00160949. [DOI] [PubMed] [Google Scholar]
  • 20.Aleman TS, LaVail MM, Montemayor R, Ying G, Maguire MM, Laties AM, Jacobson SG, Cideciyan AV. Augmented rod bipolar cell function in partial receptor loss: an ERG study in P23H rhodopsin transgenic and aging normal rats. Vision Res. 2001;41:2779–2797. doi: 10.1016/s0042-6989(01)00157-2. [DOI] [PubMed] [Google Scholar]
  • 21.Wurziger K, Lichtenberger T, Hanitzsch R. On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. Vision Res. 2001;41:1091–1101. doi: 10.1016/s0042-6989(01)00026-8. [DOI] [PubMed] [Google Scholar]
  • 22.Hansen RM, Fulton AB. The course of maturation of rod-mediated visual thresholds in infants. Invest Ophthalmol Vis Sci. 1999;40:1883–1886. [PubMed] [Google Scholar]
  • 23.Wetherill GB, Levitt H. Sequential estimation of points on a psychometric function. Br J Math Stat Psychol. 1965;18:1–10. doi: 10.1111/j.2044-8317.1965.tb00689.x. [DOI] [PubMed] [Google Scholar]
  • 24.Pugh EN., Jr . Vision: Physical and retinal physiology. In: Atkinson RC, et al., editors. Stevens Handbook of Experimental Psychology, Volume 1, Perception and Motivation. 2nd. New York: Wiley; 1988. pp. 75–163. [Google Scholar]
  • 25.McCulloch DL, Hamilton R. Essentials of photometry for clinical electrophysiology of vision. Doc Ophthalmol. 2010;121:77–84. doi: 10.1007/s10633-010-9233-2. [DOI] [PubMed] [Google Scholar]
  • 26.Hansen RM, Fulton AB. Psychophysical estimates of ocular media density of human infants. Vision Res. 1989;29:687–690. doi: 10.1016/0042-6989(89)90031-x. [DOI] [PubMed] [Google Scholar]
  • 27.Mactier H, Maroo S, Bradnam M, Hamilton R. Ocular biometry in preterm infants: implications for estimation of retinal illuminance. Invest Ophthalmol Vis Sci. 2008;49:453–457. doi: 10.1167/iovs.07-0540. [DOI] [PubMed] [Google Scholar]
  • 28.Brown AM, Dobson V, Maier J. Visual acuity of human infants at scotopic, mesopic and photopic luminances. Vision Res. 1987;27:1845–1858. doi: 10.1016/0042-6989(87)90113-1. [DOI] [PubMed] [Google Scholar]
  • 29.Hansen RM, Fulton AB. Recovery of the rod photoresponse in infants. Invest Ophthalmol Vis Sci. 2005;46:764–768. doi: 10.1167/iovs.04-0257. [DOI] [PubMed] [Google Scholar]
  • 30.Malcolm CA, Hamilton R, McCulloch DL, Montgomery C, Weaver LT. Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci. 2003;44:3685–3691. doi: 10.1167/iovs.02-0767. [DOI] [PubMed] [Google Scholar]
  • 31.Fulton AB, Hansen RM. The development of scotopic sensitivity. Invest Ophthalmol Vis Sci. 2000;41:1588–1596. [PubMed] [Google Scholar]
  • 32.Hansen RM, Fulton AB. The VEP thresholds for full-field stimuli in dark-adapted infants. Vis Neurosci. 1995;12:223–228. doi: 10.1017/s0952523800007902. [DOI] [PubMed] [Google Scholar]
  • 33.Akula JD, Favazza TL, Mocko JA, Benador IY, Asturias AL, Kleinman MS, Hansen RM, Fulton AB. The anatomy of the rat eye with oxygen-induced retinopathy. Doc Ophthalmol. 2010;120:41–50. doi: 10.1007/s10633-009-9198-1. [DOI] [PubMed] [Google Scholar]
  • 34.Lu M, Hansen RM, Cunningham MJ, Eklund SE, Fulton AB. Effects of desferoxamine on retinal and visual function. Arch Ophthalmol. 2007;125:1581–1582. doi: 10.1001/archopht.125.11.1581. [DOI] [PubMed] [Google Scholar]
  • 35.Marc RE, Jones BW. Retinal remodeling in inherited photoreceptor degenerations. Mol Neurobiol. 2003;28:139–147. doi: 10.1385/MN:28:2:139. [DOI] [PubMed] [Google Scholar]
  • 36.Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res. 2003;22:607–655. doi: 10.1016/s1350-9462(03)00039-9. [DOI] [PubMed] [Google Scholar]
  • 37.Marc RE, Jones BW, Watt CB, Vazquez-Chona F, Vaughan DK, Organisciak DT. Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol Vis. 2008;14:782–806. [PMC free article] [PubMed] [Google Scholar]
  • 38.Akula JD, Mocko JA, Benador IY, Hansen RM, Favazza TL, Vyhovsky TC, Fulton AB. The neurovascular relation in oxygen-induced retinopathy. Mol Vis. 2008;14:2499–2508. [PMC free article] [PubMed] [Google Scholar]
  • 39.Gelman R, Martinez-Perez ME, Vanderveen DK, Moskowitz A, Fulton AB. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci. 2005;46:4734–4738. doi: 10.1167/iovs.05-0646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wilson CM, Cocker KD, Moseley MJ, Paterson C, Clay ST, Schulenburg WE, Mills MD, Ells AL, Parker KH, Quinn GE, Fielder ARNg J. Computerized analysis of retinal vessel width and tortuosity in premature infants. Invest Ophthalmol Vis Sci. 2008;49:3577–3585. doi: 10.1167/iovs.07-1353. [DOI] [PubMed] [Google Scholar]
  • 41.Hammer DX, Iftimia NV, Ferguson RD, Bigelow CE, Ustun TE, Barnaby AM, Fulton AB. Foveal fine structure in retinopathy of prematurity: an adaptive optics Fourier domain optical coherence tomography study. Invest Ophthalmol Vis Sci. 2008;49:2061–2070. doi: 10.1167/iovs.07-1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Penn JS, Henry MM, Wall PT, Tolman BL. The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci. 1995;36:2063–2070. [PubMed] [Google Scholar]
  • 43.Barnett JM, Yanni SE, Penn JS. The development of the rat model of retinopathy of prematurity. Doc Ophthalmol. 2010;120:3–12. doi: 10.1007/s10633-009-9180-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Berkowitz BA, Roberts R. Evidence for a critical role of panretinal pathophysiology in experimental ROP. Doc Ophthalmol. 2010;120:13–24. doi: 10.1007/s10633-009-9175-8. [DOI] [PubMed] [Google Scholar]
  • 45.Hartnett ME. The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model. Doc Ophthalmol. 2010;120:25–39. doi: 10.1007/s10633-009-9181-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES